Diabody mixture providing full protection against experimental scorpion envenoming with crude Androctonus australis venom

Journal of Biological Chemistry

Volumn 287, Issue 17, 2012, Pages 14149-14156

  Di Tommaso, Anne ^a,b   Juste, Matthieu O ^a,b   Martin Eauclaire, Marie France ^c   Dimier Poisson, Isabelle ^a,b   Billiald, Philippe ^d   Aubrey, Nicolas ^a,b  

^a UNIVERSITÉ DE TOURS   (France)

^b UR1282   (France)

^c University of Mediterranée   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALGERIA; CRUDE VENOMS; DIABODY; IN-VITRO; IN-VIVO; INTRAPERITONEAL INJECTIONS; MOLAR RATIO; NORTH AFRICA; TUNISIA;

ANIMALS; METABOLITES;

MIXTURES;

DIABODY MIXTURE; SCORPION VENOM; UNCLASSIFIED DRUG; VENOM ANTISERUM;

ANDROCTONUS AUSTRALIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DESIGN; DRUG DEVELOPMENT; DRUG EFFECT; DRUG EFFICACY; DRUG PURIFICATION; ENVENOMATION; FEMALE; GENE SEQUENCE; IN VIVO STUDY; LD 50; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POISONOUS SCORPION; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; SURVIVAL RATE; TOXIN ANALYSIS;

ANIMALS; ANTIBODIES; ANTITOXINS; FEMALE; GENETIC ENGINEERING; IMMUNOTHERAPY; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDES; PLASMIDS; POLYMORPHISM, GENETIC; RECOMBINANT PROTEINS; SCORPION VENOMS; SCORPIONS; TIME FACTORS;

EID: 84859962399     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.348912     Document Type: Article

References (40)

1. Chippaux, J. P., and Goyffon, M. (2008) Epidemiology of scorpionism. A global appraisal. Acta Trop. 107, 71-79
2. Prendini, L., and Wheeler, W. C. (2005) Scorpion higher phylogeny and classification, taxonomic anarchy, and standards for peer review in on-line publishing. Cladistics 21, 446-494 (Pubitemid 43899780)
3. Chowell, G., Díaz-Dueñas, P., Bustos-Saldaña, R., Mireles, A. A., and Fet, V. (2006) Epidemiological and clinical characteristics of scorpionism in Colima, Mexico (2000-2001). Toxicon 47, 753-758 (Pubitemid 43786341)
4. Bouaziz, M., Bahloul, M., Kallel, H., Samet, M., Ksibi, H., Dammak, H., Ahmed, M. N., Chtara, K., Chelly, H., Hamida, C. B., and Rekik, N. (2008) Epidemiological, clinical characteristics, and outcome of severe scorpion envenomation in South Tunisia. Multivariate analysis of 951 cases. Toxicon 52, 918-926
5. Adi-Bessalem, S., Hammoudi-Triki, D., and Laraba-Djebari, F. (2008) Pathophysiological effects of Androctonus australis hector scorpion venom. Tissue damages and inflammatory response. Exp. Toxicol. Pathol. 60, 373-380
6. Benguedda, A. C., Laraba-Djébari, F., Ouahdi, M., Hellal, H., Griene, L., Guerenik, M., Laid, Y., and Comité National de Lutte Contre l'Envenimation Scorpionique (CNLES) (2002) Fifteen years' experience in scorpion envenomation control in Algeria. Bull. Soc. Pathol. Exot. 95, 205-208
7. Njah, M., Ben Abdelaziz, A., Abdouli, M., Zaher, M., and Garaoui, A. (2001) Health program and use of community health workers. The example of scorpion envenomation in Tunisia. Sante 11, 57-62
8. Mansour, N. (2001) Delay and characteristics of scorpion bite management in the Sidi-Bouzid region. Arch. Inst. Pasteur Tunis 78, 25-31
9. el Ayeb, M., and Rochat, H. (1985) Polymorphism and quantitative variations of toxins in the venom of the scorpion Androctonus australis hector. Toxicon 23, 755-760
10. el Ayeb, M., Bahraoui, E. M., Granier, C., and Rochat, H. (1986) Use of antibodies specific to defined regions of scorpion α-toxin to study its interaction with its receptor site on the sodium channel. Biochemistry 25, 6671-6678 (Pubitemid 17217919)
11. Delori, P., Van Rietschoten, J., and Rochat, H. (1981) Scorpion venoms and neurotoxins. An immunological study. Toxicon 19, 393-407
12. Devaux, C., Jouirou, B., Naceur Krifi, M., Clot-Faybesse, O., El Ayeb, M., and Rochat, H. (2004) Quantitative variability in the biodistribution and in toxinokinetic studies of the three main α toxins from the Androctonus australis hector scorpion venom. Toxicon 43, 661-669 (Pubitemid 38520770)
13. Martin, M. F., and Rochat, H. (1986) Large scale purification of toxins from the venom of the scorpion Androctonus australis Hector. Toxicon 24, 1131-1139 (Pubitemid 17215081)
14. Abroug, F., ElAtrous, S., Nouira, S., Haguiga, H., Touzi, N., and Bouchoucha, S. (1999) Serotherapy in scorpion envenomation. A randomized controlled trial. Lancet 354, 906-909
15. Krifi, M. N., Savin, S., Debray, M., Bon, C., El Ayeb, M., and Choumet, V. (2005) Pharmacokinetic studies of scorpion venom before and after antivenom immunotherapy. Toxicon 45, 187-198 (Pubitemid 40051148)
16. Hammoudi-Triki, D., Lefort, J., Rougeot, C., Robbe-Vincent, A., Bon, C., Laraba-Djebari, F., and Choumet, V. (2007) Toxicokinetic and toxicodynamic analyses of Androctonus australis hector venom in rats. Optimization of antivenom therapy. Toxicol. Appl. Pharmacol. 218, 205-214 (Pubitemid 46201696)
17. Krifi, M. N., Miled, K., Abderrazek, M., and El Ayeb, M. (2001) Effects of antivenom on Buthus occitanus tunetanus (Bot) scorpion venom pharmacokinetics. Toward an optimization of antivenom immunotherapy in a rabbit model. Toxicon 39, 1317-1326
18. 2, and Fab fractions of scorpion and snake antivenins. Merits and potential for therapeutic use. Toxicon 36, 1523-1528
19. Hmila, I., Abdallah, R B. A., Saerens, D., Benlasfar, Z., Conrath, K., Ayeb, M. E., Muyldermans, S., and Bouhaouala-Zahar, B. (2008) VHH, bivalent domains, and chimeric heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI. Mol. Immunol. 45, 3847-3856
20. Abderrazek, R. B., Hmila, I., Vincke, C., Benlasfar, Z., Pellis, M., Dabbek, H., Saerens, D., El Ayeb, M., Muyldermans, S., and Bouhaouala-Zahar, B. (2009) Identification of potent nanobodies to neutralize the most poisonous polypeptide from scorpion venom. Biochem. J. 424, 263-272
21. Meddeb-Mouelhi, F., Bouhaouala-Zahar, B., Benlasfar, Z., Hammadi, M., Mejri, T., Moslah, M., Karoui, H., Khorchani, T., and El Ayeb, M. (2003) Immunized camel sera and derived immunoglobulin subclasses neutralizing Androctonus australis hector scorpion toxins. Toxicon 42, 785-791 (Pubitemid 38125038)
22. Aubrey, N., Muzard, J., Christophe Peter, J., Rochat, H., Goyffon, M., Devaux, C., and Billiald, P. (2004) Engineering of a recombinant Fab from a neutralizing IgG directed against scorpion neurotoxin AahI, and functional evaluation versus other antibody fragments. Toxicon 43, 233-241 (Pubitemid 38367954)
23. Devaux, C., Moreau, E., Goyffon, M., Rochat, H., and Billiald, P. (2001) Construction and functional evaluation of a single-chain antibody fragment that neutralizes toxin AahI from the venom of the scorpion Androctonus australis hector. Eur. J. Biochem. 268, 694-702 (Pubitemid 32862627)
24. Mousli, M., Devaux, C., Rochat, H., Goyffon, M., and Billiald, P. (1999) A recombinant single-chain antibody fragment that neutralizes toxin II from the venom of the scorpion Androctonus australis hector. FEBS Lett. 442, 183-188 (Pubitemid 29070830)
25. Juárez-González, V. R., Riaño-Umbarila, L., Quintero-Hernández, V., Olamendi-Portugal, T., Ortiz-León, M., Ortíz, E., Possani, L. D., and Becerril, B. (2005) Directed evolution, phage display, and combination of evolved mutants. A strategy to recover the neutralization properties of the scFv version of BCF2, a neutralizing monoclonal antibody specific to scorpion toxin Cn2. J. Mol. Biol. 346, 1287-1297 (Pubitemid 40248829)
26. Holliger, P., and Hudson, P. J. (2005) Engineered antibody fragments and the rise of single domains. Nat. Biotechnol. 23, 1126-1136 (Pubitemid 41486394)
27. +-channel toxins protects against experimental scorpion envenoming. Cell. Mol. Life Sci. 64, 206-218
28. Hmila, I., Saerens, D., Ben Abderrazek, R., Vincke, C., Abidi, N., Benlasfar, Z., Govaert, J., El Ayeb, M., Bouhaouala-Zahar, B., and Muyldermans, S. (2010)Abispecific nanobody to provide full protection against lethal scorpion envenoming. FASEB J. 24, 3479-3489
29. Aubrey, N., Devaux, C., Sizaret, P. Y., Rochat, H., Goyffon, M., and Billiald, P. (2003) Design and evaluation of a diabody to improve protection against a potent scorpion neurotoxin. Cell. Mol. Life Sci. 60, 617-628 (Pubitemid 36459540)
30. Miranda, F., Kupeyan, C., Rochat, H., Rochat, C., and Lissitzky, S. (1970) Purification of animal neurotoxins. Isolation and characterization of 11 neurotoxins from the venoms of the scorpions Androctonus australis hector, Buthus occitanus tunetanus, and Leiurus quinquestriatus quinquestriatus. Eur. J. Biochem. 16, 514-523
31. Devaux, C., Clot-Faybesse, O., Pugnière, M., Mani, J. C., Rochat, H., and Granier, C. (2002) A strategy for inducing an immune response against Androctonus australis scorpion venom toxin I in mice. Production of high affinity monoclonal antibodies and their use in a sensitive two-site immunometric assay. J. Immunol. Methods 271, 37-46 (Pubitemid 35346365)
32. Sambrook J., R. D. W. (2001) in Molecular Cloning: A Laboratory Manual (Sambrook, J., and Russel, D. W., eds) Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
33. Appel, R. D., Bairoch, A., and Hochstrasser, D. F. (1994) A new generation of information retrieval tools for biologists. The example of the ExPASy WWWserver. Trends Biochem. Sci. 19, 258-260 (Pubitemid 24184168)
34. Muzard, J., Adi-Bessalem, S., Juste, M., Laraba-Djebari, F., Aubrey, N., and Billiald, P. (2009) Grafting of protein L binding activity onto recombinant antibody fragments. Anal. Biochem. 388, 331-338
35. Chippaux, J. P., and Goyffon, M. (1998) Venoms, antivenoms, and immunotherapy. Toxicon 36, 823-846
36. Dart, R. C., and McNally, J. (2001) Efficacy, safety, and use of snake antivenoms in the United States. Ann. Emerg. Med. 37, 181-188 (Pubitemid 32142966)
37. Tomlinson, I. M., Walter, G., Marks, J. D., Llewelyn, M. B., and Winter, G. (1992) The repertoire of human germ line VH sequences reveals about 50 groups of VH segments with different hypervariable loops. J. Mol. Biol. 227, 776-798
38. Muyldermans, S. (2001) Single domain camel antibodies. Current status. J. Biotechnol. 74, 277-302
39. Harmsen, M. M., and De Haard, H. J. (2007) Properties, production, and applications of camelid single-domain antibody fragments. Appl. Microbiol. Biotechnol. 77, 13-22 (Pubitemid 47573319)
40. Benkhadir, K., Kharrat, R., Cestèle, S., Mosbah, A., Rochat, H., El Ayeb, M., and Karoui, H. (2004) Molecular cloning and functional expression of the α-scorpion toxin BotIII. Pivotal role of the C-terminal region for its interaction with voltage-dependent sodium channels. Peptides 25, 151-161